Pfizer's Q1 Earnings Exceed Expectations Despite COVID Vaccine Sales Decline.
TL;DR Summary
Pfizer's Q1 earnings were largely in line with analysts' estimates, but revenue exceeded expectations. The company also reaffirmed its 2023 outlook, despite concerns that Covid-19 sales may fall short this year. Pfizer's stock rose following the news.
- Pfizer Stock Jumps After Sales Beat. There's More Good News From Earnings. Barron's
- Pfizer earnings and revenue top expectations despite Covid vaccine sales decline CNBC
- Will Pfizer (PFE) Beat Expectations This Earnings Season? Yahoo Finance
- All eyes on Pfizer earnings as Q1 saw focus on M&A, RSV vaccine race Seeking Alpha
- Pfizer beats profit estimates as new drugs offset COVID products slump Reuters
- View Full Coverage on Google News
Reading Insights
Total Reads
0
Unique Readers
16
Time Saved
0 min
vs 1 min read
Condensed
62%
98 → 37 words
Want the full story? Read the original article
Read on Barron's